ArticleEuropean journal of nuclear medicine and molecular imaging2019

Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson's disease.

Jenny Ceccarini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.